CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4/A Derivatives Options or other derivatives
- 4 Grant or award Vice President of Sales acquired 5,494 shares (grant or award)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Grant or award Pres & Chief Operating Officer acquired 54,945 shares (grant or award)
- 4 Grant or award Chief Technology Officer acquired 107,142 shares (grant or award)
- 4 Grant or award VP of Finance acquired 32,967 shares (grant or award)
- 4 Grant or award VP of Quality Assurance acquired 2,747 shares (grant or award)
- 4 Grant or award VP of Reg. and Clin. Affairs acquired 10,989 shares (grant or award)
- 4 Grant or award VP Research and Development acquired 13,736 shares (grant or award)
- 4 Grant or award CEO acquired 109,890 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 27,472 shares (grant or award)
- 4 Grant or award Director acquired 27,472 shares (grant or award)
- 4 Grant or award Director acquired 5,494 shares (grant or award)
- 4 Grant or award VP of Operations acquired 13,736 shares (grant or award)
- 4 Open-market buy Director bought 54,945 shares at $1.82 ($100,000)
- 4 Open-market buy 10% owner bought 1,648,359 shares at $1.82 ($3,000,013)
- 4 Open-market buy 10% owner bought 1,098,901 shares at $1.82 ($2,000,000)
Page 7 of 13 · 243 filings